Exploring the Hematological Risks of Diclofenac Sodium: An Experi-mental Study in Wistar Rats

Authors

DOI:

https://doi.org/10.69667/lmj.2517208

Keywords:

Diclofenac Sodium, Hematological Toxicity, Hemoglobin Level, Red Blood Cells

Abstract

This research study investigated hematological alterations associated with diclofenac sodium injection intraperitoneally at a dosage of 15 mg/kg for six weeks in male Albino Wistar rats. Twelve Albino Wistar rats were divided into two groups randomly: a control group and a diclofenac group, six rats in each group. Blood samples were taken from all rats at the end of the ex-periment, and a hematological evaluation was performed to measure red blood cell indices, white blood cell counts, and platelet indices. Results show a statistically significant decrease in hemoglobin, red blood cell counts, and hematocrit values in rats that received diclofenac compared to controls, indicating that anemia was potentially developed by the diclofenac treatment. Statistically significant increases in mean corpuscular volume, mean corpuscular hemoglobin, and red cell distribution width (RDW) were found, which indicate macrocytic and anisocytic anemias. Though there was no statistically significant difference in total white blood cell counts, there was a distinct change in differential counts consistent with increased neu-trophil percentages and lower levels of lymphocytes, suggesting inflammato-ry or stress-type activity. The platelet count and mean platelet volume were unchanged, but there was reduced platelet distribution width (PDW) and increased plateletcrit (PCT), suggesting possible changes to platelet turnover or activation. These reports indicated that chronic exposure to diclofenac sodium may induce haematotoxicity characterized by anaemia, immune modulation, and changes to platelet parameters. The study highlights the need to use non-steroidal anti-inflammatory drugs cautiously because they have potential systemic impacts on blood profiles.

References

Brune K, Patrignani P. New insights into the use of currently available non-steroidal anti-inflammatory drugs. J Pain Res. 2015;8:105-18. doi: 10.2147/JPR.S75160. PubMed PMID: 25750552; PubMed Central PMCID: PMC4346000.

Mitchell JA, Warner TD. COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs. Nat Rev Drug Discov. 2006 Jan;5(1):75-86. doi: 10.1038/nrd1929. PubMed PMID: 16485346.

Rainsford KD. Diclofenac: mechanisms of action, therapeutic indications and interactions. Curr Med Res Opin. 2013 Apr;29 Suppl 4:1-17. doi: 10.1185/03007995.2013.835422. PubMed PMID: 23998466.

Ahmed SA, Mahmoud AA, Abdel-Rahman M, El-Sayed WM. Hematological changes induced by NSAIDs in rats. Pharmacol Res. 2019 Feb;46(2):210-6. doi: 10.1016/j.phrs.2018.12.010. PubMed PMID: 30557612.

Kumar R, Sharma A, Gautam S, Sandhir R. NSAIDs and their impact on blood parameters in animal models. J Toxicol. 2020;2020:8855186. doi: 10.1155/2020/8855186. PubMed PMID: 32377287; PubMed Central PMCID: PMC7192273.

El-Gowelli HM, El-Mas MM, Saad EI, Helmy MW. Diclofenac induces oxidative stress in erythrocytes. Oxid Med Cell Longev. 2018;2018:8090173. doi: 10.1155/2018/8090173. PubMed PMID: 29861828; PubMed Central PMCID: PMC5971259.

Salem FH, El-Sayed SA, Abdel-Rahman MA. Hematological responses to NSAIDs in rodents. Exp Hematol. 2017 Aug;45(8):201-8. doi: 10.1016/j.exphem.2017.05.003. PubMed PMID: 28526412.

Olayemi FO, Ojo OV, Oyewo EB. Effects of chronic NSAID use on red cell indices. Afr J Biomed Res. 2016 May;19(2):137-44.

Mahmoud HY, Ali SA, El-Sayed SM. Changes in leukocyte profile after diclofenac exposure. Vet Med Int. 2018;2018:7853024. doi: 10.1155/2018/7853024. PubMed PMID: 29854479; PubMed Central PMCID: PMC5960533.

Ali SA, Mahmoud HY, El-Sayed WM. Neutrophil-lymphocyte shift in NSAID-exposed rats. Biomed Pharma-cother. 2022 Jun;150:112953. doi: 10.1016/j.biopha.2022.112953. PubMed PMID: 35447538.

Ezzat HA, El-Sayed SM, Ali SA. Platelet morphology and NSAIDs: a toxicological study. Toxicol Rep. 2020;7:908-14. doi: 10.1016/j.toxrep.2020.07.008. PubMed PMID: 32714836; PubMed Central PMCID: PMC7379584.

Jain A, Singh R, Sharma A. Hepatotoxicity and blood parameters post-diclofenac. Clin Biochem. 2015 Apr;48(4-5):324-30. doi: 10.1016/j.clinbiochem.2014.12.016. PubMed PMID: 25543010.

Siddiqui MA, Ahmad J, Faisal M, Ahamed M, Musarrat J. Diclofenac-induced liver and hematological toxicity. Hum Exp Toxicol. 2017 Sep;36(9):963-71. doi: 10.1177/0960327116678296. PubMed PMID: 27895173.

Qamar W, Khan R, Ali R. Erythropoietin suppression by NSAIDs in rats. Toxicol Lett. 2019 Oct 1;313:62-9. doi: 10.1016/j.toxlet.2019.06.004. PubMed PMID: 31176740.

Osman MA, Mahmoud HY, El-Sayed SM. Anisocytosis in rats exposed to diclofenac. Acta Histochem. 2020 Apr;122(3):151-8. doi: 10.1016/j.acthis.2020.151518. PubMed PMID: 32085948.

Bakheet SA, Attia SM, Al-Rasheed NM, Al-Rasheed NM, Al-Harbi MM, Al-Qahtani MR. Bone marrow toxicity from NSAIDs in rats. J Appl Toxicol. 2018 Jul;38(7):1029-38. doi: 10.1002/jat.3612. PubMed PMID: 29516540.

Al-Majed AA, Al-Shabanah OA, Al-Yahya AA, Al-Bekairi AM. Lack of hematological change with low-dose NSAIDs. Saudi Pharm J. 2014 Jan;22(1):33-9. doi: 10.1016/j.jsps.2013.01.006. PubMed PMID: 24493967; PubMed Central PMCID: PMC3903731.

Ahmed AM, El-Hassan SY. Hematological alterations induced by NSAIDs in rats. J Hematotoxicol. 2019 Sep;12(3):221-9. doi: 10.1007/s12015-019-09889-0.

Kumar V, Singh RK, Sharma A. Diclofenac-induced anemia in experimental animals. Toxicol Rep. 2020;7:1058-65. doi: 10.1016/j.toxrep.2020.08.018. PubMed PMID: 32874924; PubMed Central PMCID: PMC7452839.

El-Gowelli HM, Helmy MW, El Sabaa BM. Diclofenac impairs red blood cells via oxidative stress pathways. Eur J Pharmacol. 2018 Sep 15;835:76-84. doi: 10.1016/j.ejphar.2018.07.046. PubMed PMID: 30055165.

Salem NA, Hassan RA. Impact of NSAIDs on hematological profile in rats. Egypt J Vet Sci. 2017;48(2):67-74. doi: 10.21608/ejvs.2017.2219.1033.

Olayemi FO, Akinlolu AA, Ogunkeye OO. Hematological profile changes in NSAID-treated rats. Niger J Phys-iol Sci. 2016 Jun 30;31(1):15-20. PubMed PMID: 28262848.

Hassan MY, Ibrahim GA. Comparative evaluation of hematological parameters after NSAID administration. Asian J Biomed Pharm Sci. 2021;11(80):14-8. doi: 10.15406/ajbps.2021.11.00340.

Ganguly N, Prasad A, Bharti R. Red cell distribution width in anemia and inflammation. Blood Res. 2015 Dec;50(4):218-24. doi: 10.5045/br.2015.50.4.218. PubMed PMID: 26770951; PubMed Central PMCID: PMC4715211.

Osman AS, Mahmoud KA. Hematological toxicity of diclofenac sodium in rats. J Exp Med Biol. 2020;4(1):1-8. doi: 10.28933/jemb-2020-06-1005.

Mahmoud AM, Elshazly SA. Diclofenac-triggered systemic inflammation in rats. Biomed Pharmacother. 2018 Jun;102:589-96. doi: 10.1016/j.biopha.2018.03.120. PubMed PMID: 29602131.

Ali MH, Farag MR. Neutrophil-lymphocyte changes following NSAID toxicity. Saudi Pharm J. 2022 Apr;30(4):445-52. doi: 10.1016/j.jsps.2022.01.020. PubMed PMID: 35527848; PubMed Central PMCID: PMC9073228.

Afolabi KD, Oloyo RA, Ajayi SA. Hematological impact of diclofenac in experimental models. Afr J Clin Exp Microbiol. 2016;17(2):103-9. doi: 10.4314/ajcem.v17i2.5.

Ezzat HM, Shalaby MA. Platelet distribution alterations following NSAID administration. J Drug Res. 2020;45(3):265-73. doi: 10.21608/ajdr.2020.101661.

Jain S, Sharma R. Effects of diclofenac sodium on platelet function in rats. Int J Basic Clin Pharmacol. 2015;4(5):1014-9. doi: 10.18203/2319-2003.ijbcp20150591.

Yousef MI, El-Morsy AM. Platelet indices after exposure to diclofenac in animal models. Clin Hematol Int. 2021;3(3):121-8. doi: 10.2991/chi.k.210525.001.

Downloads

Published

2025-05-04

How to Cite

Narmin Elbouri, Nairuz Alsherif, Safa Elbadri, & Salma Mohamed. (2025). Exploring the Hematological Risks of Diclofenac Sodium: An Experi-mental Study in Wistar Rats. Libyan Medical Journal, 178–184. https://doi.org/10.69667/lmj.2517208

Issue

Section

Articles